Medication

Oral GLP-1 options: prices by provider and plan

Pill-form GLP-1 medications: oral semaglutide tablets and orforglipron, a non-peptide oral GLP-1 receptor agonist. Distinct from compounded sublingual or ODT preparations, which are not FDA-approved. Below: every priced offering in our dataset, sorted by monthly equivalent, with the evidence status of each figure. This page describes pricing and disclosure — it is not dosing or treatment advice.

All priced offerings (3)

Providers offering oral glp-1 options

• Hims & Hers — dispensing pharmacy not publicly disclosed

Related research in the casebook

• ATTAIN-1 — Orforglipron for chronic weight management
• OASIS 4 — Oral semaglutide 25 mg for weight management

What this page can't tell you

Whether any of these prices is current (capture dates are shown; prices in this market change monthly), what dose a listed plan actually covers unless stated, whether a compounded preparation's quality matches any standard, and whether this medication is appropriate for you — that last one is a question for a licensed clinician, full stop. What we can tell you is which claims have sources and which don't: as of this build, no oral glp-1 options price here has been independently verified by us — see the pricing verification methodologyfor what verification would require.